These data also show that GBM with the signature (high mTOR and microglia enrichment) display stronger depletion of activated lymphocytes compared to GBM without the signature, a phenotype potentially driven by mTOR‐dependent TAM‐MG activity. Here, MTOR is linked to glioblastoma.